FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
The Pharma Data
NOVEMBER 21, 2021
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth. People with achondroplasia have a genetic mutation that causes a certain growth regulation gene called fibroblast growth factor receptor 3 to be overly active, which prevents normal bone growth. Source link: [link].
Let's personalize your content